{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:29:44Z","timestamp":1761182984648,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Daiichi Sankyo Co., Ltd."},{"name":"Sumitomo Dainippon Pharma Co., Ltd."},{"name":"Kyorin Pharmaceutical Co., Ltd."},{"name":"Shionogi & Co., Ltd."},{"name":"Daiichi Sankyo Co., Ltd."},{"name":"Taisho-Toyama Pharmaceutical Co., Ltd."},{"name":"Taiho Pharmaceutical Co., Ltd."},{"name":"Toyama Chemical Co., Ltd."},{"name":"FUJIFILM Pharma Co., Ltd."},{"name":"Meiji Seika Pharma Co., Ltd."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jiac.2017.08.009","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:40:03Z","timestamp":1514508003000},"page":"83-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis"],"prefix":"10.1016","volume":"24","author":[{"given":"Hajime","family":"Nakai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.08.009_bib1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa011265","article-title":"Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group","volume":"345","author":"Manges","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.08.009_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-1282-4","article-title":"Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies","volume":"15","author":"Fasugba","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2017.08.009_bib3","article-title":"Dissemination of extended-spectrum \u03b2-lactamases and quinolone resistance genes among clinical isolates of uropathogenic Escherichia coli in children","volume":"8","author":"Sedighi","year":"2015","journal-title":"J\u00a0Microbiol"},{"key":"10.1016\/j.jiac.2017.08.009_bib4","first-page":"210","article-title":"Fluoroquinolone-resistance mechanisms and phylogenetic background of clinical Escherichia coli strains isolated in south-east Poland","volume":"39","author":"Korona-Glowniak","year":"2015","journal-title":"New Microbiol"},{"key":"10.1016\/j.jiac.2017.08.009_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.phrp.2014.08.010","article-title":"Molecular investigation of quinolone resistance of quinolone resistance-determining region in Streptococcus pneumoniae strains isolated from Iran using polymerase chain reaction-restriction fragment length polymorphism method","volume":"5","author":"Kargar","year":"2014","journal-title":"Osong Public Health Res Perspect"},{"key":"10.1016\/j.jiac.2017.08.009_bib6","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/AAC.40.10.2321","article-title":"Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae","volume":"40","author":"Pan","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/dkg269","article-title":"The mutant selection window and antimicrobial resistance","volume":"52","author":"Drlica","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"year":"2014","series-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization","key":"10.1016\/j.jiac.2017.08.009_bib8"},{"key":"10.1016\/j.jiac.2017.08.009_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.08.009_bib10","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/AAC.49.7.2903-2913.2005","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003","volume":"49","author":"Reinert","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib11","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/jac\/dkg465","article-title":"Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance program","volume":"52","author":"Canton","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10156-009-0713-9","article-title":"Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China","volume":"15","author":"Zhang","year":"2009","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib13","first-page":"411","article-title":"In\u00a0vitro activity of sitafloxacin against clinical isolates in 2009","volume":"63","author":"Amano","year":"2010","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.jiac.2017.08.009_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10156-006-0434-2","article-title":"Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory or otorhinological infections: comparison with the results obtained from organisms isolated about 10 years ago","volume":"12","author":"Hasegawa","year":"2006","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijantimicag.2008.06.032","article-title":"Clinical studies of garenoxacin","volume":"32","author":"Takagi","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2017.08.009_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jiac.2015.02.008","volume":"21","author":"Yanagihara","year":"2015","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/JCM.42.3.1185-1191.2004","article-title":"Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin","volume":"42","author":"P\u00e9rez-V\u00e1zquez","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2017.08.009_bib18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1099\/jmm.0.073734-0","article-title":"Molecular analysis of low-level fluoroquinolone resistance in clinical isolates of Moraxella catarrhalis","volume":"63","author":"Yamada","year":"2014","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.jiac.2017.08.009_bib19","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 27th ed..M100-S27. Wayne, PA."},{"key":"10.1016\/j.jiac.2017.08.009_bib20","unstructured":"Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. M45, 3rd ed..M45-A2.Wayne, PA."},{"key":"10.1016\/j.jiac.2017.08.009_bib21","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/AAC.49.4.1633-1635.2005","article-title":"Mutant prevention concentrations of ABT-492, levofloxacin, moxifloxacin, and gatifloxacin against three common respiratory pathogens","volume":"49","author":"Elizabeth","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0732-8893(00)00147-4","article-title":"In\u00a0vitro characterization of fluoroquinolone concentration\/MIC antimicrobial activity and resistance while simulating clinical pharmacokinetics of levofloxacin, ofloxacin, or ciprofloxacin against Streptococcus pneumoniae","volume":"37","author":"Madaras-Kelly","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2017.08.009_bib23","first-page":"1","article-title":"Evaluation of levofloxacin dosage regimens to prevent the appearance of resistant mutants in Streptococcus pneumoniae and Escherichia coli using an in\u00a0vitro simulation model","volume":"57","author":"Kanda","year":"2009","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib24","first-page":"1","article-title":"Phase I study of levofloxacin in healthy and elderly volunteers","volume":"57","author":"Shiba","year":"2009","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib25","first-page":"158","article-title":"Phase I study of T-3262, a new pyridine-carboxylic acid derivative","volume":"360","author":"Nakashima","year":"1988","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib26","first-page":"154","article-title":"Pharmacokinetics of sitafloxacin (DU-6859a) in healthy volunteers","volume":"56","author":"Nakashima","year":"2008","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib27","first-page":"95","article-title":"Phase 1 clinical studies of oral garenoxacin in healthy Japanese adult subjects","volume":"55","author":"Uchida","year":"2007","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib28","first-page":"12","article-title":"Levofloxacin 500mg pharmacokinetics in patients with impaired renal function","volume":"57","author":"Hanaoka","year":"2009","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10156-005-0420-0","article-title":"Pharmacodynamic evaluation of tosufloxacin against Streptococcus pneumoniae in an in\u00a0vitro model simulating serum concentration","volume":"12","author":"Fukuda","year":"2006","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib30","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1128\/AAC.01372-06","article-title":"Pharmacodynamic assessment based on mutant prevention concentrations of fluoroquinolones to prevent the emergence of resistant mutants of Streptococcus pneumoniae","volume":"51","author":"Homma","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1128\/AAC.00301-16","article-title":"Effect of fluoroquinolones and macrolides on eradication and resistance of Haemophilus influenzae in chronic obstructive pulmonary disease","volume":"60","author":"Pettigrew","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jgar.2016.03.002","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: results from the CARTIPS antimicrobial surveillance program","volume":"5","author":"Zhang","year":"2016","journal-title":"J\u00a0Glob Antimicrob Resist"},{"key":"10.1016\/j.jiac.2017.08.009_bib33","first-page":"79","article-title":"Albekacin resistant Gene,aacA\/aphD, in Staphylococcus aureus is lost during in\u00a0vitro passage","volume":"50","author":"Chen","year":"2002","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.jiac.2017.08.009_bib34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.43.3.672","article-title":"Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in\u00a0vitro model of infection","volume":"43","author":"Lacy","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.08.009_bib35","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/jac\/dkg152","article-title":"AUC0-t\/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in\u00a0vitro infection model","volume":"51","author":"Zelenitsky","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17301885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17301885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:02Z","timestamp":1761159422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17301885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1341321X17301885"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.08.009","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}